News

MedPage Today6h
Finerenone Gets Expanded FDA Approval in Heart Failure
The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.
FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says
It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually ...
Medical groups urge Kennedy, FDA to reexamine broad approval of abortion drugs
Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...
Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...
FDA adds new blue food dye from gardenia fruit
The U.S. Food and Drug Administration on Monday approved the use of a new blue color additive from the gardenia fruit the ...
FDA approves new blue food dye derived from gardenia fruit
The U.S. Food and Drug Administration approved a new blue color additive derived from the fruit of the gardenia, a flowering ...
FDA accepts MAHA-approved natural gardenia blue food dye
The Gardenia Blue Interest Group, which petitioned the government to approve the dye, has asked the FDA to make an exemption for the dye from being labeled as an allergen due to the soy protein. Soy ...
FDA approves long-acting drug to protect dogs against fleas, ticks
The FDA has approved a long-acting drug to protect dogs against fleas and ticks. The drug, Bravecto Quantum, is given by ...
WEHT Evansville on MSN7h
FDA approves new color, encourages faster phase-out of Red No. 3
The U.S. Food and Drug Administration announced it had granted Gardenia Blue Interest Group’s (GBIG) color additive petition ...
Fierce Biotech4d
FDA releases ‘initial batch’ of more than 200 drug rejection letters
The FDA has released an “initial batch“ of more than 200 complete response letters (CRLs) in efforts to boost transparency. | ...
MPR12h
FDA Drug Approval Decisions Expected in August 2025
The FDA is expected to decide on treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis.
The American Journal of Managed Care11h
FDA Approves Finerenone for Heart Failure With Mildly Reduced or Preserved LVEF
Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...